Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
Rebecca Howell,1 Adrienne M Wright,1 Jennifer N Clements2 1Presbyterian College School of Pharmacy, Clinton, SC 29325, USA; 2Department of Pharmacy Practice, Presbyterian College School of Pharmacy, Clinton, SC 29325, USA Abstract: Metformin is the first-line therapy for the management of type 2 dia...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-04-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinical-potential-of-liraglutide-in-cardiovascular-risk-reduction-in--peer-reviewed-article-DMSO |